UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy

Neurotherapeutics, 2022-04, Vol.19 (3), p.1007-1017

2022

Link zum Volltext

Verfügbarkeit prüfen

Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma

Bone (New York, N.Y.), 2012-01, Vol.50 (1), p.171-181

2012

Link zum Volltext

Verfügbarkeit prüfen

Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation

Frontiers in genetics, 2014, Vol.5, p.8

2014

Link zum Volltext

Verfügbarkeit prüfen

Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines

PloS one, 2012-09, Vol.7 (9), p.e43720

2012

Link zum Volltext

Verfügbarkeit prüfen

Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9189

2022

Link zum Volltext

Verfügbarkeit prüfen

N-acetylcysteine Pharmacology and Applications in Rare Diseases-Repurposing an Old Antioxidant

Antioxidants, 2023-06, Vol.12 (7), p.1316

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities

Orphanet journal of rare diseases, 2021-10, Vol.16 (1), p.1-446, Article 446

2021

Link zum Volltext

Verfügbarkeit prüfen

Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status

Journal of pharmaceutical sciences, 2015-08, Vol.104 (8), p.2619-2626

2015

Link zum Volltext

Verfügbarkeit prüfen

N -Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

Biomedicines, 2021-12, Vol.9 (12), p.1826

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial

Pilot and feasibility studies, 2018-10, Vol.4 (1), p.162-162, Article 162

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular Interactions between Gasotransmitters in Patients with Obstructive Sleep Apnea

International journal of translational medicine, 2022-08, Vol.2 (3), p.408-418

2022

Link zum Volltext

Verfügbarkeit prüfen

N-acetylcysteine Provides Cytoprotection in Murine Oligodendrocytes through Heme Oxygenase-1 Activity

Biomedicines, 2020-07, Vol.8 (8), p.240

2020

Link zum Volltext

Verfügbarkeit prüfen

Gaucher disease – more than just a rare lipid storage disease

Journal of molecular medicine (Berlin, Germany), 2022-04, Vol.100 (4), p.499-518

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients with Gaucher disease display systemic oxidative stress dependent on therapy status

Molecular genetics and metabolism reports, 2020-12, Vol.25, p.100667-100667, Article 100667

2020

Link zum Volltext

Verfügbarkeit prüfen

Repeated‐Dose Oral N‐Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress

Journal of clinical pharmacology, 2018-02, Vol.58 (2), p.158-167

2018

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs as Biomarkers in Cancer

Diagnostics, 2013-01, Vol.3 (1), p.84-104

2013

Link zum Volltext

Verfügbarkeit prüfen

Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1254-1263

2022

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-mediated gene regulations in human sarcomas

Cellular and molecular life sciences : CMLS, 2012-11, Vol.69 (21), p.3571-3585

2012

Link zum Volltext

Verfügbarkeit prüfen

GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.35-46

2020

Link zum Volltext

Verfügbarkeit prüfen

Translational and clinical pharmacology considerations in drug repurposing for X‐linked adrenoleukodystrophy—A rare peroxisomal disorder

British journal of clinical pharmacology, 2022-06, Vol.88 (6), p.2552-2563

2022

Link zum Volltext

Verfügbarkeit prüfen

N-Acetyl-L-cysteine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage: Implications for Age-Related Macular Degeneration

Oxidative medicine and cellular longevity, 2019, Vol.2019, p.5174957-14

2019

Link zum Volltext

Verfügbarkeit prüfen

Gaucher disease and SARS-CoV-2 infection: Emerging management challenges

Molecular genetics and metabolism, 2020-07, Vol.130 (3), p.164-169

2020

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic Analysis of N‐Acetylcysteine in Pediatric Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplant

Journal of clinical pharmacology, 2021-12, Vol.61 (12), p.1638-1645

2021

Link zum Volltext

Verfügbarkeit prüfen

Orphan drug development: the increasing role of clinical pharmacology

Journal of pharmacokinetics and pharmacodynamics, 2019-10, Vol.46 (5), p.395-409

2019

Link zum Volltext

Verfügbarkeit prüfen

Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy

Journal of inherited metabolic disease, 2020-05, Vol.43 (3), p.564-573

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(57)
Buchkapitel
(1)

Sprache

Englisch
(58)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy

Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma

Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation

Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines

Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease

N-acetylcysteine Pharmacology and Applications in Rare Diseases-Repurposing an Old Antioxidant

Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities

Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status

N -Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial

Molecular Interactions between Gasotransmitters in Patients with Obstructive Sleep Apnea

N-acetylcysteine Provides Cytoprotection in Murine Oligodendrocytes through Heme Oxygenase-1 Activity

Gaucher disease – more than just a rare lipid storage disease

Patients with Gaucher disease display systemic oxidative stress dependent on therapy status

Repeated‐Dose Oral N‐Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress

MicroRNAs as Biomarkers in Cancer

Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions

MicroRNA-mediated gene regulations in human sarcomas

GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies

Translational and clinical pharmacology considerations in drug repurposing for X‐linked adrenoleukodystrophy—A rare peroxisomal disorder

N-Acetyl-L-cysteine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage: Implications for Age-Related Macular Degeneration

Gaucher disease and SARS-CoV-2 infection: Emerging management challenges

Population Pharmacokinetic Analysis of N‐Acetylcysteine in Pediatric Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplant

Orphan drug development: the increasing role of clinical pharmacology

Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy

Suchergebnisse filtern